๐ฐ Cell Engineering News
Page 8 - Cell Engineering News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cell Engineering. Real-time updates on events, politics, business and more.
January 13, 2022
The multidisciplinary team will develop a biomaterial bridge to help regrow nerve fibres in the spine Spinal cord injury (SCI) is damage to the spinal
December 20, 2021
Cardiologist Ronald Berger, neurologist Ted Dawson, and biomedical engineer Jordan Green are among 164 selected to join the academy this year
December 7, 2021
How do proteins help in biomedical imaging? Andre: Proteins are molecules made out of amino acids. In our bodies and in all life forms, proteins have
November 5, 2021
The program for recent Hopkins alums offers career training, mentorship, and a front-row seat to learning about strategy and decision making at JHU
October 27, 2021
A 3-year, $8.9 million grant is funding a research study on how abnormal protein aggregates may spread from the gut to the brain to drive the early stages of Parkinson's disease.
October 27, 2021
Dr. Michael Kaplitt, a professor of neurological surgery at Weill Cornell Medicine and a longtime leader in developing cutting-edge surgical therapies for movement disorders, leads a team that has been awarded a three-year, $8.9 million grant from the Aligning Science Across Parkinson's (ASAP) initiative.
October 27, 2021
Dr. Michael Kaplitt, a professor of neurological surgery at Weill Cornell Medicine and a longtime leader in developing cutting-edge surgical therapies
October 27, 2021
The Immunology and Allergology Centre will be established on the basis of Belarusโ National Academy of Sciences, following a decision made...
October 27, 2021
Johns Hopkins Medicine researchers share in grant to study the impact of the gut on the development of Parkinsonโs disease Johns Hopkins Medicine is
October 22, 2021
“The first prototypes were developed in May this year; full-fledged prototypes containing substances that enhance the immune response were created at the end of June. Laboratory tests have been completed, they have shown good results. Now pre-clinical trials are underway,”Andrei Goncharov said.